In vitro
diagnostics (IVDs) provide valuable information regarding the physiological
and/or pathological state of body and therefore are very essential to take
well-informed medical decisions. Rising number of patients suffering from infectious
and chronic diseases such as sexually transmitted diseases, chronic obstructive
pulmonary disease, diabetes and cancer is the most significant growth driver of
this market. In addition, factors such as increasing global healthcare
expenditure and demand for rapid, minimally invasive and non-invasive
diagnostic tools & techniques are driving the market as well.

In
2011, the North America IVD market held the second largest share of the global market
at approximately 40%. The Asia-Pacific IVD market is expected to outperform all
geographies in terms of growth rate during the forecast period. Presence of
large patient pool and rising healthcare expenditure in these regions are responsible
for this growth.

The clinical
chemistry segment of the market held the largest market share across all major
geographic regions such as the U.S., China and India in 2011. However, increase
in demand for molecular diagnostics in the IVD market is expected to cut into
the market share of clinical chemistry by 2018.

In
2011, Roche Diagnostics (Roche Group) held the largest share in the global in vitro
diagnostics market followed by Siemens Healthcare (Siemens AG). Some of the
other major companies involved in the development, manufacturing and
distribution of in vitro diagnostics are Johnson & Johnson, Beckman Coulter
Inc., Becton Dickinson and Company, Gen-Probe Incorporated and Thermo Fisher
Scientific Corporation.

The
global in vitro diagnostics market is categorized into the following segments:

§ Market by Products

o U.S.

§
Clinical Chemistry

§
Immunoassay

§
Diabetes Testing

§
Blood Testing

§
Molecular Diagnostics

§
Others (Flow Cytometry, Microbiological
Diagnostic Techniques)

o India

§
Clinical Chemistry

§
Immunoassay

§
Diabetes Testing

§
Blood Testing

§
Molecular Diagnostics

§
Others (Flow Cytometry, Microbiological
Diagnostic Techniques)

o China

§
Clinical Chemistry

§
Immunoassay

§
Diabetes Testing

§
Blood Testing

§
Molecular Diagnostics

§
Others (Flow Cytometry, Microbiological
Diagnostic Techniques)

§ Market by Geography

o North
America

o Europe

o Asia-Pacific

o
Rest of the World (RoW)

About Us

TransparencyMarket Researchis a global market intelligence
company, providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are privileged
with highly experienced team of Analysts, Researchers, and Consultants, who use
proprietary data sources and various tools and techniques to gather, and
analyze information.

Our data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and information.
With a broad research and analysis capability, Transparency Market Research
employs rigorous primary and secondary research techniques in developing
distinctive data sets and research material for business reports.